Tokyo, Sept. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059202) titled 'Research on hair root responsiveness and hair growth effects' on Sept. 26.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Placebo

Primary Sponsor: Institute - Kao Corporation

Condition: Condition - Not applicable Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the relationship between the responsiveness of hair follicles and hair growth effects. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Apply hair growth product to the right side of the head twice a day for 16wks. Interventions/Control_2 - Apply hair growth product to the left side of the head twice a day for 16wks.

Eligibility: Age-lower limit - 20 years-old = Gender - Male Key inclusion criteria - 1. Japanese male aged 20-59. 2. Those whose hair condition corresponds to II vertex, II, IIa, III vertex, III, IIIa, IV, or IVa according to the Hamilton-Norwood classification. 3. Those who are not using anti hair loss products at the time of recruitment into the study, or who agree to discontinue using them from the time of receiving an explanation of the study. Key exclusion criteria - 1. Those who have allergic reactions to ethanol on the skin. 2. Those who have surgical scars on the head. 3. Those who have skin symptoms such as atopic dermatitis, contact dermatitis, seborrheic dermatitis, etc. on the scalp. 4. Those who have undergone chemical treatment of the hair within the past one month from the time of recruitment. 5. Those who are experiencing acute hair loss or hair falling out in patches. 6. Those whose gray hair ratio exceeds that of black hair when not dyed. 7. Those who are skinhead or short hair less than 4 cm in length. 8. Those who have undergone hair transplantation or hair extension. 9. Those who have used any medicines including hair regrowth agents on the scalp in the past one month. 10. Those who have orally ingested any drug that shows hair regrowth effect in the past one month. 11. Those who regularly take supplements that may have an effect of reducing skin inflammation. 12. Those who regularly take supplements that may improve or prevent hair loss. 13. Those who have a history or current history of serious illnesses such as diabetes, liver disease, renal disease, or cardiac disease. 14. Those who have received any vaccination within 2 weeks prior to the start of participation in the study. 15. Those who are planning to participate in other clinical trials or monitoring surveys during the study period. 16. Those who is otherwise deemed inappropriate as a research subject by the person in charge of conducting the research. Target Size - 24

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 09 Month 16 Day Date of IRB - 2025 Year 09 Month 16 Day Anticipated trial start date - 2025 Year 09 Month 26 Day Last follow-up date - 2026 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067713

Disclaimer: Curated by HT Syndication.